Type 2 diabetes. Diabetes mellitus with polyneuropathy
Conditions
Interventions
Intervention 1: Intervention group: Using plug in ultrasound along with an ineffective ointment. Intervention 2: Intervention group: Using plug in ultrasound along with Linoderm ointment. Intervention
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients with type 2 diabetes between 45-75 years of age and with symptoms of neuropathy in the lower limbs diagnosed by NCV.
Exclusion criteria
Exclusion criteria: The presence of neuropathy symptoms without the presence of diabetes Infectious diabetic ulcers Systemic peripheral vascular problems The presence of chronic diseases such as coronary artery disease Chronic lung diseases kidney problems History of drug allergy pregnancy Reluctance to cooperate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain with Numeric Pain Rating Scale(NRS):It is a chart to determine the intensity of the patient's pain before and after the study. The chart is numbered from zero, meaning no pain, to 10, meaning severe pain. Timepoint: pain measurement at the beginning of the study (before the start of the intervention) and immediately after the completion of 6 treatment sessions (after two weeks from the start of the treatment) and one month after the treatment. Method of measurement: Numeric Pain Rating Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Conduction speed of sensory, motor and mixed nerves of tibial and peroneal nerves. Timepoint: Measurement of nerve conduction velocity at the beginning of the study (before the start of the study), 6 sessions after the intervention (2 weeks after the start of the treatment) and one month after the end of the treatment. Method of measurement: Measuring nerve conduction velocity by electromyography device.;Examining the presence of disorder or lack of sensation: Semmes-Weinstein 10g monofilament is used and different points (a total of 10 points) including three points on the plantar surface of the first, third and fifth toes, three points on the plantar surface of the first, third and metatarsal heads. Fifth, two points on the inner and outer sides of the middle part of the foot, one point on the heel area and one point on the back surface of the foot are evaluated. Timepoint: Measurement of sensory loss or disturbance at the beginning of the study (before the start of the intervention), 6 sessions after the treatment (2 weeks after the start of the treatment) and one month after the end of the treatment. Method of measurement: Monofilament test.;Michigan questionnaire to investigate neuropathy in diabetic patients :This questionnaire is for checking the presence of diabetic neuropathy and higher scores mean more severity of neuropathy. The first part, history, includes 15 questions about the sensations of pain, numbness, temperature, etc., which the patient answered and Each question has one mark. Of course, question 4 related to defective blood circulation and question 10, which are related to general weakness, are not included in scoring, and the maximum acquired score is 13. The second part includes a brief physical examination of the feet, which is not used in this study. Timepoint: Investigation of neuropathy at the beginning of the study (before the start of the intervention) and 6 sessions after the treatment (2 weeks after the start of the treatment) and one | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactminoo khalkhali zavieh
Shahid Beheshti University of Medical Sciences
Outcome results
None listed